Partnering with microbiologists to diagnose and prevent diseaseTM

Hospital Acquired Infections

Ensuring patient health, one test at a time.

Hospital Acquired Infections (HAIs), otherwise known as Healthcare-Associated Infections, are infections patients get while receiving medical treatment in healthcare facilities, such as a hospital, ambulatory surgical center, nursing home, etc.

HAIs present a major, but largely preventable, threat to patient safety. According to the CDC and the New England Journal of Medicine, in 2011, there were an estimated 722,000 instances of Hospital Acquired Infections in U.S. acute care hospitals. Of these, around 75,000 patients succumbed to these infections. While this figure is on the decline, Hardy Diagnostics shares the sentiment that anything above zero is too many.

Hardy Diagnostics is doing our part to help prevent further instances of HAIs with a range of products specifically designed to detect harmful bacteria before they infect a patient.

Leeds Acinetobacter Medium

Catalog no. G261

Leeds Acinetobacter Medium is a selective and differential medium intended for use as a plating technique to obtain a pure culture of Acinetobacter. The test is performed with a mixed population of microorganisms from a laboratory sample.

BCSA

Catalog no. G09

Hardy Diagnostics Burkholderia cepacia Selective Agar (BCSA) is used for the selective isolation of Burkholderia (Pseudomonas) cepacia.

HardyCHROM™ UTI

Catalog no. G313

HardyCHROM™ UTI is a non-selective chromogenic medium recommended for the cultivation, differentiation, and enumeration of urinary tract pathogens based on colony color and morphology.

HardyCHROM™ ESBL

Catalog no. G321

HardyCHROM™ ESBL is a selective and differential chromogenic medium intended for the qualitative and presumptive detection of the following from stool specimens: 1) Enterobacteriaceae that are potentially non-susceptible to ceftazidime and cefpodoxime; and 2) Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca.

HardyCHROM™ MRSA

Catalog no. G307

HardyCHROM™ MRSA is a selective and differential chromogenic medium recommended for the qualitative detection of nasal colonization by methicillin-resistant Staphylococcus aureus (MRSA) to aid in the prevention and control of MRSA infections in healthcare settings.

BCYE Agar

Catalog no. P251

Buffered Charcoal Yeast Extract (BCYE) Agar formulations are recommended for use in the cultivation and primary isolation of Legionella spp. in water and other samples suspected of harboring the bacteria.

HardyCHROM™ MRSA

Catalog no. P14

HardyCHROM™ MRSA, Contact Plate is a chromogenic medium recommended for use in the cultivation of methicillin-resistant Staphylococcus aureus (MRSA) from environmental surfaces to aid in the prevention and control of MRSA infections in health care settings.

C. diff Banana Broth™

Catalog no. K226

C. diff Banana Broth™ (Clostridium difficile Brucella Broth with Thioglycolic Acid and L-cystine or CDBB-TC) is recommended for the culture and recovery of Clostridium difficile spores and vegetative cells from environmental samples.

Cetrimide Select Agar

Catalog no. G18

Hardy Diagnostics Cetrimide Selective Agar is recommended for the selective isolation and identification of Pseudomonas aeruginosa.

AnaeroGRO™ Cycloserine-Cefoxitin Fructose Agar (CCFA)

Catalog no. AG501

Hardy Diagnostics AnaeroGro™ Cycloserine-Cefoxitin Fructose Agar (CCFA) is an enriched selective and differential medium recommended for the cultivation and isolation of Clostridium difficile from fecal specimens. C. difficile is a recognized cause of intestinal infections and pseudomembranous colitis following antibiotic therapy.